Steve Schonfeld’s Disc Medicine IRON Stock Holding History

Steve Schonfeld’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,333	Closed	-$404K	–	2336
2021 Q3	$404K	Buy	+3,333	New	+$456K	﹤0.01%	1372

Other funds holding IRON

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Steve Schonfeld's IRON Position: Q2 2025 in Review

Steve Schonfeld sold out of Disc Medicine (IRON) in Q2 2025, closing a stake of 7,552 shares — an estimated $375K sold.

Steve Schonfeld first reported a position in IRON in Q2 2023 and held it in 8 quarters. The position peaked at $3.02M in Q1 2024. 151 funds tracked by Wall St. Rank hold IRON as of Q2 2025.

Steve Schonfeld reported no remaining Disc Medicine position as of Q2 2025 after selling out during the quarter.
Steve Schonfeld sold 7,552 Disc Medicine shares in Q2 2025, an estimated $375K.
Steve Schonfeld first reported a position in Disc Medicine in Q2 2023 and held it in 8 quarters.
Steve Schonfeld's Disc Medicine position peaked at $3.02M in Q1 2024.
151 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.